NUFORMIX LTD has a total of 35 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Hong Kong. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are BIOELECTRON TECH CORP, JOUVEINAL INST RECH and SPEEDEL PHARMA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Hong Kong | 4 | |
#4 | United States | 4 | |
#5 | Canada | 3 | |
#6 | Brazil | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Argentina | 1 | |
#10 | Australia | 1 | |
#11 | Israel | 1 | |
#12 | India | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Holland Joanne | 30 |
#2 | Frampton Christopher | 27 |
#3 | Chorlton Alan | 20 |
#4 | Gooding Daniel | 20 |
#5 | Joanne Holland | 3 |
#6 | Christopher Frampton | 3 |
#7 | Alan Chorlton | 2 |
#8 | Daniel Gooding | 2 |
Publication | Filing date | Title |
---|---|---|
WO2013144916A1 | Tranilast compositions and cocrystals | |
CN108640910A | Aprepitant L-PROLINE solvate-composition and eutectic | |
CN103476753A | Novel rebamipide complexes and cocrystals | |
AU2011306391A1 | Aprepitant L-proline composition and cocrystal | |
WO2011158110A2 | Cilostazol cocrystals and compositions | |
WO2011077252A2 | Metaxalone cocrystals |